Plasmodium falciparum susceptibility to anti-malarial drugs in Dakar, Senegal, in 2010: an ex vivo and drug resistance molecular markers study

BACKGROUND: In 2006, the Senegalese National Malaria Control Programme recommended artemisinin-based combination therapy (ACT) as the first-line treatment for uncomplicated malaria. Since the introduction of ACT, there have been very few reports on the level of resistance of P. falciparum to anti-ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Fall, Bécaye, Pascual, Aurélie, Sarr, Fatoumata D, Wurtz, Nathalie, Richard, Vincent, Baret, Eric, Diémé, Yaya, Briolant, Sébastien, Bercion, Raymond, Wade, Boubacar, Tall, Adama, Pradines, Bruno
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606842/
https://www.ncbi.nlm.nih.gov/pubmed/23510258
http://dx.doi.org/10.1186/1475-2875-12-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606842/
https://www.ncbi.nlm.nih.gov/pubmed/23510258
http://dx.doi.org/10.1186/1475-2875-12-107

Ejemplares similares